Tudisco, Riccardo
Tudisco, Riccardo
Impact of mRNA-based vaccines in the prevention of adverse outcomes of COVID-19 infection in pregnancy: a single-center cohort study
2023 Tudisco, Riccardo; Garufi, Cristina; Rizzo, Francesca; Polimeno, Teresa; Lanzone, Antonio; De Carolis, Sara
BRCA status and platinum sensitivity in advanced ovarian cancer according to Chemotherapy Response Score
2022 Ergasti, Raffaella; Marchetti, Claudia; Tudisco, Riccardo; Iervolino, A.; Naldini, A.; Oliva, Riccardo; Inzani, Frediano; Scambia, Giovanni; Fagotti, Anna
The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer
2022 Bizzarri, Nicolò; D'Indinosante, Marco; Marchetti, Claudia; Tudisco, Riccardo; Turchiano, Francesca; Scambia, Giovanni; Fagotti, Anna
What’s beyond BRCA Mutational Status in High Grade Serous Ovarian Cancer? The Impact of Hormone Receptor Expression in a Large BRCA-Profiled Ovarian Cancer Patient Series: A Retrospective Cohort Study
2022 Perrone, E.; Tudisco, Riccardo; Pafundi, Pia Clara; D'Aniello, Guido Edoardo; Ciucci, A.; Martinelli, E.; Zannoni, Gian Franco; Piermattei, Angelo; Spadola, S.; Ferrante, Maria Giulia; Marchetti, Claudia; Scambia, Giovanni; Fagotti, Anna; Gallo, D.
Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: A phase II, open label multicenter study (NUVOLA trial)
2021 Marchetti, Claudia; Tudisco, Riccardo; Salutari, Vanda; Pietragalla, A.; Scambia, Giovanni; Fagotti, Anna
External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response
2020 Zorzato, Pier Carlo; Zannoni, Gian Franco; Tudisco, Riccardo; Pasciuto, Tina; Di Giorgio, Andrea; Franchi, Massimo; Scambia, Giovanni; Fagotti, Anna
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2023 | Impact of mRNA-based vaccines in the prevention of adverse outcomes of COVID-19 infection in pregnancy: a single-center cohort study | Tudisco, Riccardo; Garufi, Cristina; Rizzo, Francesca; Polimeno, Teresa; Lanzone, Antonio; De Carolis, Sara | |
| 1-gen-2022 | BRCA status and platinum sensitivity in advanced ovarian cancer according to Chemotherapy Response Score | Ergasti, Raffaella; Marchetti, Claudia; Tudisco, Riccardo; Iervolino, A.; Naldini, A.; Oliva, Riccardo; Inzani, Frediano; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2022 | The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer | Bizzarri, Nicolò; D'Indinosante, Marco; Marchetti, Claudia; Tudisco, Riccardo; Turchiano, Francesca; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2022 | What’s beyond BRCA Mutational Status in High Grade Serous Ovarian Cancer? The Impact of Hormone Receptor Expression in a Large BRCA-Profiled Ovarian Cancer Patient Series: A Retrospective Cohort Study | Perrone, E.; Tudisco, Riccardo; Pafundi, Pia Clara; D'Aniello, Guido Edoardo; Ciucci, A.; Martinelli, E.; Zannoni, Gian Franco; Piermattei, Angelo; Spadola, S.; Ferrante, Maria Giulia; Marchetti, Claudia; Scambia, Giovanni; Fagotti, Anna; Gallo, D. | |
| 1-gen-2021 | Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: A phase II, open label multicenter study (NUVOLA trial) | Marchetti, Claudia; Tudisco, Riccardo; Salutari, Vanda; Pietragalla, A.; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2020 | External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response | Zorzato, Pier Carlo; Zannoni, Gian Franco; Tudisco, Riccardo; Pasciuto, Tina; Di Giorgio, Andrea; Franchi, Massimo; Scambia, Giovanni; Fagotti, Anna |